We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Research

Cancer Research

Kate Robinson profile page

Science Editor

at Technology Networks

Kate graduated from Sheffield Hallam University with a bachelor's degree in biomedical sciences in 2020. During her studies, she developed a passion for science communication and after graduating, began a science blog in order to continue writing about trending science news and topics of interest. She joined the editorial team at Technology Networks in 2021. In her role as science editor Kate supports the publication’s in-house writers, produces scientific content across all communities and works closely with the managing editor to help coordinate commissioned pieces.

Education

Sheffield Hallam University

Accreditations

Biomedical Science BSc (Hons) recognised by Sheffield Hallam University

Areas of Expertise

Biomedical Science

Science Communication

Got a Question for Kate Robinson?

Get in touch using the contact form linked here and we'll get back to you shortly.

Content Written By, Reviewed By, or Featuring Kate Robinson

Total: 107

A rack of test tubes containing separated blood plasma and cells, suitable for use in droplet digital PCR (ddPCR) analysis.

Industry Insight

Revolutionizing Cancer Testing With ddPCR

In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in minimal residual disease detection, the development of a ddPCR-based ESR1 assay and the evolving role of liquid biopsy in cancer diagnostics.

Science icons surround an image of Max Fisher. Text reads: Bringing Your Whole Self To The Lab: An Interview With Max Fisher

Bringing Your Whole Self to the Lab: An Interview With Max Fisher

Queer scientist Max Fisher shares insights on identity, inclusion and the simple changes that help create safer, more supportive lab spaces for LGBTQIA+ researchers.

Science icons surround an image of Hazel Ang. Text reads: Claiming Space in STEMM: An Interview With Hazel X. Ang

Claiming Space in STEMM: An Interview With Hazel X. Ang

Dr. Hazel X. Ang shares their experiences navigating STEMM, reflecting on progress, remaining barriers and the everyday actions that make research environments more inclusive.

A gloved hand picks up a biopharmaceutical vial.

Industry Insight

Speeding Up Safety: How ddPCR Is Changing Mycoplasma Testing

In this interview, Dr. Denise Teber, a scientific expert in molecular biology at Charles River Laboratories, discusses how ddPCR is being used to improve contamination risk management.

Neurons with amyloid plaques, illustrating Alzheimer’s disease.

Industry Insight

Automating Brain Organoids To Boost Neurodegenerative Research

In this interview, Felix Spira, senior manager at Molecular Devices, discusses how automation and AI improve brain organoid cultivation, enabling consistent long-term models that advance research into complex neurodegenerative diseases.

Magnifying glass highlighting a yellow capsule among various blue and white pills during drug screening.

Industry Insight

From Hits to Leads: Improving Early Drug Discovery With Better Tools

In this interview, Dr. Iain Yisu Wang from MedChemExpress discusses the growing role of AI, the value of phenotypic screening and how tailored compound libraries are helping researchers keep up with the increasing complexity of drug discovery.

3D rendering of a degenerating neuron, illustrating nerve cell damage linked to Alzheimer's disease.

Industry Insight

Breaking Diagnostic Barriers in Alzheimer’s With Fluid Biomarkers

Technology Networks recently spoke with Cristiano Tunesi to learn more about how cerebrospinal fluid biomarkers are transforming Alzheimer’s diagnosis, offering earlier and more accurate detection to guide treatment and improve outcomes.

Molecular structure emerging from capsules, symbolizing drug discovery in functional proteomics.

Industry Insight

Advancing Drug Discovery With Functional Proteomics

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate instrumentation, software and consumables to support early-stage pharma innovation.

Hand holding a weight loss drug injector above a bathroom scale with feet in socks.

The Promise and Perils of Weight Loss Drugs

This article examines the rise of GLP-1 weight loss drugs, highlighting their effectiveness in obesity and diabetes management while addressing concerns over side effects, mental health risks, high costs and long-term sustainability.

The gloved hands of a scientist holding badges displaying various LGBTQIA+ pride flags.

Creating Space in Science: LGBTQIA+ Voices on Belonging in Pharma

In this listicle, LGBTQIA+ scientists offer insights into how inclusion can be built into everyday lab culture, from normalizing pronoun sharing and celebrating diverse holidays to rethinking policy and representation.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter